Patent details
90842 Product Name: MabCampath-Alemtuzumab et ses dérivés pharmaceutiquement acceptables
Basic Information
- Publication number:
- 90842
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP893012914
- Legal Status:
- Expired
- Application number:
- 90842
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/01/193/001
- Marketing Authorization Type:
- Marketing Authorization Date:
- 06/07/2001
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 26/09/2001
- First Marketing Authorization date:
- 06/07/2001
- Grant date:
- 26/11/2001
- Activation date:
- 10/02/2009
- Publication date:
- 26/11/2001
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 10/02/2014
- SPC Extension Expiration:
- 10/02/2014
- Rejection date:
- Withdrawal date:
Owner
- From:
- 26/09/2001
- Name:
- BTG INTERNATIONAL LIMITED
- Address:
- FLEET PLACE, LIMEBURNER LANE 5, LONDON EC4M 7RD, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 26/09/2001
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
| Filing date | Document type | Number of pages |
|---|